Wells Fargo & Company Greenwich Life Sciences, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,839 shares of GLSI stock, worth $23,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,839
Previous 1,911
3.77%
Holding current value
$23,097
Previous $32,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GLSI
# of Institutions
38Shares Held
1.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA274KShares$3.44 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.68 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.09 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL74.5KShares$935,7200.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $161M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...